Cargando…

Re: Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”: The Authors Respond

Detalles Bibliográficos
Autores principales:	Kang, Kyusik, Lee, Jung-Ju, Kim, Byung-Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169916/ https://www.ncbi.nlm.nih.gov/pubmed/36929063 http://dx.doi.org/10.3988/jcn.2022.0468

Ejemplares similares

Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19
por: Kang, Kyusik, et al.
Publicado: (2022)

Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”
por: Finsterer, Josef
Publicado: (2023)

Steroid-responsive aseptic meningitis after BNT162b2 SARS-CoV-2 vaccine
por: Reis Carneiro, D., et al.
Publicado: (2022)

Re: Comments on “Neuromuscular Ultrasonography of Cranial Nerves”: The Authors Respond
por: Tawfik, Eman A., et al.
Publicado: (2017)

Aseptic meningitis after BNT-162b2 COVID-19 vaccination
por: Chan, Amanda CY., et al.
Publicado: (2021)

Amoxicillin-induced aseptic meningoencephalitis
por: Shahien, Radi, et al.
Publicado: (2010)

Relapsing Polychondritis and Aseptic Meningoencephalitis
por: Yokota, Kazuhiro, et al.
Publicado: (2022)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination
por: Lee, Hyoung Cheol, et al.
Publicado: (2022)

Neuro-Sweet syndrome - a rare differential diagnosis in aseptic meningoencephalitis
por: Hoffmann, Elgin, et al.
Publicado: (2019)

Re: Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
por: Yoo, Dallah, et al.
Publicado: (2022)

Re: Comments on “Pure or Complex Hereditary Spastic Paraplegia Type 4?”: The Authors Respond
por: Yang, Jiwon, et al.
Publicado: (2019)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

RE: Comments on "Unilateral Reversible Posterior Leukoencephalopathy Syndrome after Coiling of an Aneurysm": The Authors Respond
por: Huijgen, Willemijn, et al.
Publicado: (2014)

Re: Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study: authors' response
por: Shasha, David, et al.
Publicado: (2022)

Oropouche Virus–Associated Aseptic Meningoencephalitis, Southeastern Brazil
por: Vernal, Sebastian, et al.
Publicado: (2019)

Generalized Polyspike Pattern in EEG Due to Aseptic Meningoencephalitis
por: Hobert, Markus A., et al.
Publicado: (2023)

Aseptic meningoencephalitis after COVID-19 vaccination: A case report
por: Ahmad, Shwan A., et al.
Publicado: (2021)

Relapse of neuromyelitis optica spectrum disorder after BNT162b2 mRNA Covid-19 vaccination
por: Wang, Qi, et al.
Publicado: (2023)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

Decline of immune humoral response after BNT162b2 vaccine
por: Ferri, Sonia, et al.
Publicado: (2022)

Frosted branch angiitis after booster vaccination with BNT162b2
por: Haas, A.-M., et al.
Publicado: (2023)

Dual drug-induced aseptic meningoencephalitis: More than a suggestion
por: Coletti Moja, Mario, et al.
Publicado: (2021)

Comment on “Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis”
por: Ahn, Byoung June, et al.
Publicado: (2022)

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
por: Güney, Tekin, et al.
Publicado: (2022)

Spontaneous pneumomediastinum after BNT162b2 COVID-19 vaccination in adolescents
por: Lam, Chi-Yan, et al.
Publicado: (2023)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)

Erythema nodosum triggered by BNT162b2 mRNA COVID-19 vaccine
por: Juddoo, Vanessa, et al.
Publicado: (2022)

Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
por: Nishizawa, Toshinori, et al.
Publicado: (2022)

Insulin allergy manifesting soon after COVID‐19 vaccination (BNT162b2)
por: Komamura, Hiroshi, et al.
Publicado: (2022)

Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
por: Sauerwein, Kai M.T., et al.
Publicado: (2023)

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up: comment
por: Serraino, Cristina, et al.
Publicado: (2022)

Re: Comments on “A Case of MELAS With the m.3243A>G Variant of the MT-TL1 Gene Mimicking Acute Intermittent Porphyria”: The Authors Respond
por: Cai, Wenjie, et al.
Publicado: (2022)

Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study
por: Shacham-Shmueli, Einat, et al.
Publicado: (2022)

Acute myocarditis after a third dose of the BNT162b2 COVID-19 vaccine
por: Fosch, Xavier, et al.
Publicado: (2022)

Bilateral anterior uveitis after BNT162b2 mRNA vaccine: Case report
por: Duran, M.
Publicado: (2022)

Re: Comments on “Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies”: Author Response
por: Kang, Sungwoo, et al.
Publicado: (2023)

Intracranial Hypertension as an Acute Complication of Aseptic Meningoencephalitis with Leptomeningeal Contrast Enhancement on FLAIR MRI
por: Wolf, Marc E., et al.
Publicado: (2016)

Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization
por: Khehra, Nimrat, et al.
Publicado: (2021)

Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
por: Stervbo, Ulrik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0q4iau07dm7s1qn2v09dn3v8tb